Hotline
Morpholine / Related Application Product

(r)-(+)-3-hydroxypiperidine hydrochloride

  post date: nov 26,2021
  expiry date: nov 26,2022
  detailed description: cas no. :198976-43-1
quantity: 1metric tons

name: (r)-(+)-3-hydroxypiperidine hydrochloride
cas: 198976-43-1
molecular formula: c5h12clno
molecular weight: 137.608
names and identifiers
name (r)-(+)-3-hydroxypiperidine hydrochloride
synonyms (r)-(+)-3-hydroxypiperdine hydrochloride
3-piperidinol, hydrochloride, (3r)-
3-piperidinol, hydrochloride, (3s)-
(r)-(+)-3-piperidinol hydrochloride
(r)-3-piperidinol hydrochloride
(r)-(+)-3-hydroxypiperidine hydrochloride
(r)-3-hydroxypiperidine hydrochloride
(r)-3-hydroxypiperidine hydrocloride
(r)-piperidin-3-ol hydrochloride
(3r)-piperidin-3-ol hydrochloride
cas 198976-43-1
einecs 264-644-6
inchi inchi=1/c5h11no.clh/c7-5-2-1-3-6-4-5;/h5-7h,1-4h2;1h/t5-;/m1./s1
physico-chemical properties
molecular formula c5h12clno
molar mass 137.608 g/mol
melting point 195-196℃
boling point 191.9°c at 760 mmhg
flash point 104.5°c
vapor presure 0.134mmhg at 25°c
198976-43-1 – risk and safety
hazard symbols xi – irritant
irritant
risk codes r36/37/38 – irritating to eyes, respiratory system and skin.
safety description s26 – in case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
s37/39 – wear suitable gloves and eye/face protection

  cas registry number:

198976-43-1

  synonyms: ; (r)-(+)-3-hydroxypiperdine hydrochloride;3-piperidinol, hydrochloride, (3r)-;3-piperidinol, hydrochloride, (3s)-;(r)-(+)-3-piperidinol hydrochloride;(r)-3-piperidinol hydrochloride;(r)-3-hydroxypiperidine hydrochloride;(r)-3-hydroxypiperidine hydrocloride;(r)-piperidin-3-ol hydrochloride;(3r)-piperidin-3-ol hydrochloride;r-(+)-3-piperidinol hcl;r-3-hydroxy piperidine hcl;
  molecular formula: c5h12clno
  molecular weight: 137.6079
  molecular structure: 198976-43-1 (r)-(+)-3-hydroxypiperidine hydrochloride

  hazard symbols:  xi:irritant;
  risk codes: r36/37/38:;
  safety description: s26:;
s37/39:;

Prev:
Next: